Prominent Hydroxychloroquine Market Trend for 2025: Side Effects Of Hydroxychloroquine

What Are the Projected Growth and Market Size Trends for the Hydroxychloroquine Market?
The hydroxychloroquine industry has seen robust growth in recent times. The market which stood at $2.07 billion in 2024 is predicted to burgeon to $2.22 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The historical growth is linked with increased cases of malaria, growing recognition of hydroxychloroquine, abundant accessibility, and the prevalence of autoimmune diseases.

Expectations are high for the hydroxychloroquine market to significantly expand in the coming years, projecting a surge to $2.86 billion by 2029 with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period is triggered by factors such as the rising demand for combination therapies, larger government funding, an increasing patient populace, better access to healthcare, and a heightened interest in personalised medicine. Notable trends likely to emerge during this forecast period are targeted therapies, the use of telemedicine, drug repurposing, focus on sustainability and environmental impact, global health equity, and advancements in biotechnology.

What Is Driving the Growth Trajectory of the Hydroxychloroquine Market?
The rise in COVID-19 infections has fuelled the need for the hydroxychloroquine market. Hydroxychloroquine's growing demand is due to its employment in treating COVID-19 patients and the continuous clinical trials. The US Food and Drug Administration has permitted the urgent use of hydroxychloroquine for COVID-19 treatment for hospitalized patients or those participating in clinical trials. The World Health Organization's (WHO) COVID-19 Dashboard reveals that as of September 21, 2023, there has been a global reporting of 770,778,396 confirmed COVID-19 cases, leading to 6,958,499 deaths. The countries most severely hit by the virus include the USA, Brazil, Russia, the UK, India, and Spain. Thus, the constant rise in COVID-19 cases worldwide intensifies the need for hydroxychloroquine, resulting in an increase in revenue for the hydroxychloroquine market during the period.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3235&type=smp

Which Leading Companies Are Shaping the Growth of the Hydroxychloroquine Market?
Major companies operating in the hydroxychloroquine market include Bayer AG, Dr. Reddy's Laboratories Ltd., Zydus Group, Ipca Laboratories Ltd., Wallace Pharma, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Novartis AG, Intas Pharmaceuticals Ltd., Lupin Limited, Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, Sandoz International GmbH, Cipla Limited, Shenhua Pharmaceutical Co. Ltd., Sanofi S.A., Macleod Pharmaceuticals Ltd., McW Healthcare, Laurus Labs, TAJ Pharmaceuticals, Wuhan Wuyao Pharmaceutical Co. Ltd., MAAN Medex, Cinkate Corporation, Concordia Healthcare, Pfizer Inc., Cadila Pharmaceuticals, Hetero Drugs Ltd., Jubilant Generics Limited, Alembic Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Unichem Laboratories Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., Strides Pharma Science Ltd., Indoco Remedies Ltd.

What Are the Major Trends Shaping the Hydroxychloroquine Market?
The growth of the hydroxychloroquine market is expected to be curtailed due to associated side effects of its drugs. Use of hydroxychloroquine in treating COVID-19 patients has been linked to severe, even life-threatening, heart rhythm issues. In January 2022, a safety warning about the side effects of this drug when used for COVID-19 treatment outside hospitals or clinical trials was issued by the US Food and Drug Administration. To put it simply, these potential side effects impede the usage of hydroxychloroquine beyond hospital and clinical environments, presenting a challenge to the expansion of the hydroxychloroquine market in the future.

What Are the Key Segments of the Hydroxychloroquine Market?
The hydroxychloroquine market covered in this report is segmented -

1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity
2) By Formulation: Tablets, Injection
3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy

Subsegments:
1) By Anti-Malarial Drug: Treatment Of Malaria, Prophylaxis For Malaria
2) By Anti-Rheumatic Drug: Treatment Of Rheumatoid Arthritis, Treatment Of Juvenile Idiopathic Arthritis
3) By Lupus Suppressant Drug: Treatment Of Systemic Lupus Erythematosus
4) By Anti COVID-19 Drug: Treatment Of COVID-19 Symptoms
5) By Other Drug Activity: Treatment Of Other Autoimmune Disorders, Additional Off-label uses

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

Which Region Dominates the Hydroxychloroquine Market?
The countries covered in the hydroxychloroquine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Hydroxychloroquine Global Market Report?

- Market Size Analysis: Analyze the Hydroxychloroquine Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Hydroxychloroquine Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Hydroxychloroquine Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Hydroxychloroquine Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3235

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.